Skip to main content
. 2022 Jul 7;140(1):16–24. doi: 10.1182/blood.2022015728

Figure 1.

Figure 1.

Cumulative incidence of subsequent malignancies. Cumulative incidence plots showing incidence of γ retroviral genetically modified IECs vs genetically unmodified IECs.